US Patent Issued to Fred Hutchinson Cancer Center on Jan. 20 for "Methods and compositions for treating androgen receptor deficient, androgen receptor low, and castration-resistant prostate cancers" (Washington Inventor)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,764, issued on Jan. 20, was assigned to Fred Hutchinson Cancer Center (Seattle).

"Methods and compositions for treating androgen receptor deficient, androgen receptor low, and castration-resistant prostate cancers" was invented by Andrew Hsieh (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and compositions for treatment of prostate cancers, such as androgen receptor (AR) deficient androgen receptor (AR) low cancers, are disclosed. The methods include administration of an agent that inhibits activity of eIF4F or an agent that disrupts the eIF4F translation-initiation complex (composed of eIF4E, eIF4A, and eIF4G)."

The patent was fil...